Collecting and Storing Biological Samples From Young Patients With Hodgkin?s Lymphoma
Hodgkin Disease (HD) Banking Study
Sponsor: Children's Oncology Group
A observational or N/A phase clinical study on Ann Arbor Stage I Childhood Hodgkin Lymphoma and Ann Arbor Stage II Childhood Hodgkin Lymphoma, this trial is completed. The trial is conducted by Children's Oncology Group and has accumulated 13 data snapshots since 2006. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
13 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Dec 2021 — Jul 2024 [monthly]
Completed
-
Jan 2021 — Dec 2021 [monthly]
Completed
▶ Show 8 earlier versions
-
Nov 2020 — Jan 2021 [monthly]
Completed
-
May 2019 — Nov 2020 [monthly]
Completed
Status: Active Not Recruiting → Completed
-
Oct 2018 — May 2019 [monthly]
Active Not Recruiting
-
Aug 2018 — Oct 2018 [monthly]
Active Not Recruiting
-
Jun 2018 — Aug 2018 [monthly]
Active Not Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Active Not Recruiting
Phase: NA → None
-
Jun 2017 — Apr 2018 [monthly]
Active Not Recruiting NA
-
Jan 2017 — Jun 2017 [monthly]
Active Not Recruiting NA
First recorded
Oct 2006
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Children's Oncology Group
- National Cancer Institute (NCI)
For direct contact, visit the study record on ClinicalTrials.gov .